{"bill": {"#text": "\n  ", "form": {"current-chamber": {"#tail": "\n    ", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n", "congress": {"#tail": "\n    ", "#text": "113th CONGRESS"}, "#tail": "\n  ", "legis-num": {"#tail": "\n    ", "#text": "H. R. 3631"}, "official-title": {"#tail": "\n  ", "#text": "To authorize the Commissioner of Food and Drugs to waive or reduce certain fees applicable to generic drug facilities where the fees would present a significant barrier to market entry because of limited resources available to such facilities or other circumstances."}, "session": {"#tail": "\n    ", "#text": "1st Session"}, "distribution-code": {"#tail": "\n    ", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n      ", "@date": "20131202", "#text": "December 2, 2013"}, "#tail": "\n    ", "action-desc": {"#tail": "\n    ", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "HIF00", "#text": "Committee on Energy and Commerce"}, "sponsor": {"#tail": " (for himself and ", "#text": "Mr. Hurt", "@name-id": "H001060"}, "cosponsor": {"#tail": ") introduced the following bill; which was referred to the ", "#text": "Mr. Roe of Tennessee", "@name-id": "R000582"}}, "#text": "\n      "}, "legis-type": {"#tail": "\n    ", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "H8F9C6CD6537B4471A8CA9A2E74B9A47D", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n    ", "quote": {"short-title": {"#tail": "\n        ", "#text": "Small Manufacturer Protection Act of 2013"}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "HA42FBBB86C0D46E6A4243AE4C8BB3182"}, {"#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Waiver or reduction of certain fees applicable to generic drug facilities"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n        ", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 744B of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:744B"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "\n            21 U.S.C. 379j\u201342", "@value": "usc/21/379j\u201342"}, "@parsable-cite": "usc/21/379j-42", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In general"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", by inserting ", "@entity-type": "act", "#text": "subsection (b)(1)(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:744B/ss:b/p:1/sp:B"}, "#text": "in ", "quote": [{"#tail": " after ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ",", "@entity-type": "act", "#text": "subsection (c)(3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:744B/ss:c/p:3"}, "#text": ", except as provided in "}, {"#tail": "; and", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall", "@entity-type": "act", "#text": "paragraphs (2) through (4) of subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:744B/ss:a/p:2..4"}, "#text": "fees under "}]}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "H3651D643893C41629F43353F2D9741FB", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", by adding at the end the following:", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:744B/ss:c"}, "#text": "in "}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n        ", "paragraph": {"#tail": "\n            ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall grant to a person that owns a generic drug facility a waiver from or a reduction of one or more fees assessed to that person under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " where the ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:744B/ss:a"}, {"#tail": " finds that the assessment of the fee would present a significant barrier to market entry because of limited resources available to such person or other circumstances.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "header": {"#tail": "\n                ", "#text": "Standard"}, "#text": "\n                ", "@id": "H7F8A6175165E4207BF9FAA5F46E9A120"}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:744B/ss:c/p:3/sp:A", "@proposed": "true"}, {"#tail": " shall consider only the circumstances and assets of the person involved and any affiliate of the person.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "In determining whether to grant a waiver or reduction of a fee under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "header": {"#tail": "\n                ", "#text": "Considerations"}, "#text": "\n                ", "@id": "H876262E2C98F495AAD426F7247096CE1"}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", a person shall submit to the ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:744B/ss:c/p:3/sp:A", "@proposed": "true"}, {"#tail": " a written request for such waiver or reduction not later than 180 days after the fee is due.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "To qualify for consideration for a waiver or reduction under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "header": {"#tail": "\n                ", "#text": "Written requests"}, "#text": "\n                ", "@id": "H5D09C3EE35334FEC9882C955448AB131"}, {"#tail": "\n            ", "text": {"#tail": "\n              ", "term": {"#tail": " means a person that owns a facility which is identified or intended to be identified in at least one generic drug submission that is pending or approved to produce one or more finished dosage forms of a human generic drug.", "#text": "person that owns a generic drug facility"}, "#text": "In this paragraph, the term ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "header": {"#tail": "\n                ", "#text": "Definition"}, "#text": "\n                ", "@id": "HEC9978D4F2B84F43B47EEC15856C49EE"}], "enum": {"#tail": "\n              ", "#text": "(3)"}, "header": {"#tail": "\n              ", "#text": "Fee waivers"}, "#text": "\n              ", "@id": "HA701A31FC1C24F8783079A363AE88CC0"}, "@display-inline": "no-display-inline", "#text": "\n            ", "@id": "H3A50570CAE32471981B57666195CF3E4"}, "#text": "\n          ", "@id": "HFEB16ECD484C4B75AEA09718F1638A3A"}], "#text": "\n        ", "@id": "HEC01A74888C04156907F9BEE2AF3A48D"}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "#text": "The amendments made by this section apply with respect to fees authorized to be assessed and collected for any of fiscal years 2014 through 2017."}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Applicability"}, "#text": "\n        ", "@id": "H4E8E29E12E1A44E6833E9F719A44FBAC"}], "#text": "\n      ", "@id": "H4580EA8F8AA54902BFD6A7A168386550"}], "#text": "\n    ", "@id": "H2749320A1C8242E2808CF7FAD2F3EEA3"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2013-12-02"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 3631 IH: Small Manufacturer Protection Act of 2013"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}